Thor Medical ASA (FRA:8NN) 10-Year Share Buyback Ratio : -22.60% (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Thor Medical ASA 10-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

10-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past ten years. It is calculated as the annualized percentage change in shares outstanding from ten years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. Thor Medical ASA's current 10-Year Share Buyback Ratio was -22.60%.

FRA:8NN's 10-Year Share Buyback Ratio is ranked worse than
68.01% of 644 companies
in the Biotechnology industry
Industry Median: -12.55 vs FRA:8NN: -22.60

Competitive Comparison of Thor Medical ASA's 10-Year Share Buyback Ratio

For the Biotechnology subindustry, Thor Medical ASA's 10-Year Share Buyback Ratio, along with its competitors' market caps and 10-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Thor Medical ASA's 10-Year Share Buyback Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Thor Medical ASA's 10-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Thor Medical ASA's 10-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

Thor Medical ASA 10-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from ten years ago to the current year. The annualized percentage change is calculated with least-square regression based on the eleven years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Thor Medical ASA (FRA:8NN) 10-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Thor Medical ASA 10-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of Thor Medical ASA's 10-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Thor Medical ASA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Thor Medical ASA (FRA:8NN) » Definitions » 10-Year Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

TRMED:Norway 0R6Y:UK

Address

Karenslyst Alle 9C, Oslo, NOR, 0278

Website

https://www.thormedical.no

Thor Medical ASA is a Norway-based biopharmaceutical company. The Company is a producer and supplier of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium. The Company is utilizing alpha-emitters in radiotherapy and cancer treatments using Pb-212, which can be produced from naturally occurring isotope Thorium-232 and Lead-212. The Company has developed a proprietary technology for the manufacturing of radionuclides, alpha-particle emitters from natural resources. The high energy deposition and the short range of alpha particles make it possible to eradicate cancer cells while minimizing damage to nearby healthy cells.

Thor Medical ASA Headlines

No Headlines